Fundraising Fox
/Companies
Sign in

PepGen

NASDAQ: PEPG

Boston, US · Founded 2020 · 3 known investors

Find your way into PepGen

729 people in our graph can introduce you to the PepGen team.

Sign up to see every warm intro you have to PepGen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the PepGen team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

PepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.

AI & Machine LearningBiotechHealthtechMedical Devices

Founders & leadership

JMJames McArthur
James McArthurChief Executive OfficerJames McArthur is an executive with over 25 years of experience founding biotech companies and advancing drug development programs from discovery through early clinical proof-of-concept. He has served on boards of both private and public biotech firms and patient advocacy organizations.
NPNoel P. Donnelly
Noel P. DonnellyChief Financial Officer
JDJoseph D. Vittiglio
Joseph D. VittiglioChief Business & Legal OfficerJoseph D. Vittiglio is Chief Business & Legal Officer and Secretary of PepGen, a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases. He brings experience in pharmaceuticals and biotechnology, with expertise in licensing collaborations, partnerships, mergers and acquisitions, and regulatory and manufacturing operations.
KKKasra Kasraian
Kasra KasraianChief Technical Officer

Board

RFRamin Farzaneh-Far
Ramin Farzaneh-FarExecutive Chairman2020–2021Venture Partner at RA Capital
JR
Joshua ResnickBoard director
CAChristopher Ashton
Christopher AshtonBoard directorAdvisor, Life Sciences at Oxford Science Enterprises
HHHeidi Henson
Heidi HensonBoard MemberExecutive Officer at Kura Oncology

Investors · 3

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

Viking Globallisted by Viking GlobalStamford

How we know: Viking Global's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

$126.9M disclosed across 2 of 4 rounds · 2020–2025

  • Undisclosed amountpublic offeringSep 2025
    Source ↗
▶$112.5MraisedAug 2021 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ramin Farzaneh-FarDirector
  • Joshua ResnickDirector
  • Christopher AshtonDirector
  • James McArthurExecutive Officer, Director
  • Heidi HensonDirector
Offering amount
$112.5M
Amount sold
$112.5M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.4MraisedDec 2020 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew WoodDirector
  • Caroline GodfreyExecutive Officer, Director
  • Josh ResnickDirector
  • Ramin Farzaneh-FarDirector
  • Christopher AshtonDirector
Offering amount
$51.8M
Amount sold
$14.4M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does PepGen do?
PepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
Who are PepGen's investors?
PepGen's investors include Oxford Science Enterprises, RA Capital, Viking Global.
How much funding has PepGen raised?
PepGen has disclosed $126.9M raised across 2 of its 4 known rounds.
Where is PepGen headquartered?
PepGen is headquartered in Boston, US.